Skip to content

Pain relief in patients with lower limb removed from body

Role of extended duration pulsed radiofrequency on pain relief in chronic post amputation lower limb pain : a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009527
Enrollment
12
Registered
2017-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Age group of 18 to 80 years History of post-amputation lower limb pain of at least four months Health Condition 2: 8- Other Procedures

Interventions

Intervention1: Two cycle of PRF: at 42 degrees for 120 seconds Control Intervention1: One cycles of PRF: at 42degrees for 120 seconds

Sponsors

Department of Anaesthesia and Intensive Care
Lead Sponsor
Department of Science and Technology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: History of post-amputation limb pain of at least four months Failure of conservative therapy (eg, physiotherapy, medication trial) Pain score more than or equal to 5

Exclusion criteria

Exclusion criteria: Patient refusal to participate, Any contraindication to dorsal root ganglion A history of predominant back pain over leg pain, significant anatomic deformity (either congenital or acquired) making it difficult to access the foramen as evidenced by computed tomography/magnetic resonance imaging, Severe psychiatric illness, Allergy to local anesthetics or contrast medium Uncontrolled Diabetics, cardiovascular, hepatic and renal disorder. Patients with cardiac pacemakers and implantable cardioverter defibrillator. Pregnancy Red flag signs including infection, tumor, fracture and neurological deficit

Design outcomes

Primary

MeasureTime frame
Recording of pain scores 11-point VNRSTimepoint: at 1, 3 and 6 months

Secondary

MeasureTime frame
Reduction of dosage of pre procedure drugs Anxiety and depression scores Any adverse effectsTimepoint: At 1, 3 and 6 month

Countries

India

Contacts

Public ContactVanita Ahuja

GMCH

vanitaanupam@gmail.com09646121649

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026